Curve Biosciences Funding: $40M Raised, Series A (2025)
Curve Biosciences is a Biotech company based in Dallas. It has raised $40M in total funding. Latest round: Series A.
Curve Biosciences funding overview
Curve Biosciences is a Biotech company based in Dallas. Curve Biosciences has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2025. The round record for Curve Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Luma Group, First Spark Ventures, Techas Capital, Civilization Ventures, LifeX Ventures, Incite.org and 2 others. 8 distinct backers are named across the disclosed rounds.
Curve Biosciences has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Curve Biosciences?
Luma Group, First Spark Ventures, Techas Capital, Civilization Ventures, LifeX Ventures, Incite.org are named among the investors backing Curve Biosciences.
What was the latest Curve Biosciences funding round?
The most recent disclosed round is a Series A, announced in November 2025.
Where is Curve Biosciences based?
Curve Biosciences is based in Dallas.
What sector does Curve Biosciences operate in?
Curve Biosciences is tracked under Biotech from Dallas, with $40M in disclosed funding.
When did Curve Biosciences last raise?
The last disclosed Curve Biosciences round closed in November 2025 at Series A.
Round data for Curve Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Dallas and backer lists below.
